Company profile
Proteomedix company profile
Proteomedix (an Onconetix company; NASDAQ:ONCO) is a healthcare company whose mission is to transform prostate cancer diagnosis. The company has identified novel biomarker signatures with utility in prostate cancer diagnosis, prognosis and therapy management. The lead product Proclarix® is a blood based prostate cancer test panel and risk score currently available in Europe. Proteomedix is located in the Bio-Technopark of Zurich-Schlieren, Switzerland.
Business identity
- Website
- http://proteomedix.com
- Contact email
- [email protected]
- Phone number
- 0041 44 733 40 90
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2010-03-01
Headquarters
- Headquarters
- Schlieren, Zurich, Switzerland
- Postal code
- 8952
- Country code
- CH
- Continent
- Europe